Results 61 to 70 of about 1,884 (156)

Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐Clavulanate

JEADV Clinical Practice, Volume 5, Issue 2, Page 669-672, June 2026.
ABSTRACT Acute generalised exanthematous pustulosis (AGEP) is a rare, acute neutrophilic dermatosis most commonly triggered by drugs, which typically resolves within 2 weeks following withdrawal of the causative agent. Topical and systemic corticosteroids remain the standard treatment.
Alexandra Junge, Charlotte Vogel, Theresa Hempel, Basil Signer, Nikhil Yawalkar, Kristine Heidemeyer   +5 more
wiley   +1 more source

A case of recalcitrant acute generalized exanthematous pustulosis with Sjogren's syndrome: Successfully treated with low‐dose cyclosporine

Clinical Case Reports, 2019
Acute generalized exanthematous pustulosis (AGEP) is a reaction attributed mainly to drugs. Hydroxychloroquine is a rare cause of AGEP especially used in rheumatology and dermatology.
Zeynep Gizem Kaya İslamoğlu, Pınar Karabağli   +1 more
doaj   +1 more source

Hydroxychloroquine Patch Test Positivity in a Patient With Systemic Lupus Erythematosus

Contact Dermatitis, Volume 95, Issue 2, Page 231-233, August 2026.
Alexa G. Ries, Zachary Frost, Zachary Hopkins, Jamie P. Schlarbaum   +3 more
wiley   +1 more source

Leucomycin-induced acute generalized exanthematous pustulosis complicated with pitting edema of the legs

Dermatologica Sinica, 2015
Acute generalized exanthematous pustulosis (AGEP) is characterized by fever, sterile nonfollicular pustules, and neutrophilia. More than 90% of cases of AGEP are induced by antibiotics such as aminopenicillins and macrolides.
Chu-Ju Hung, Jen-Jung Cheng, Po-Ju Lai, Wea-Lung Lin, Yu-Ping Hsiao   +4 more
doaj   +1 more source

Before Diagnosing IVIG‐Refractory Kawasaki Disease: Distinguishing Persistent KD Inflammation From AGEP‐Related Drug Fever

Clinical Case Reports, Volume 14, Issue 6, June 2026.
Muhammad Abdullah Awan, Hammad‐ud‐din Raza   +1 more
wiley   +1 more source

Acute Generalized Exanthematous Pustulosis Induced by Olanzapine

Acta Medica, 2006
The case of a 56 years old man is presented, who developed acute generalized exanthematous pustulosis 5 days after the introduction of olanzapine 10 mg.
Susanne Christen, Félix Gueissaz, Romain Anex, Daniele Fabio Zullino   +3 more
doaj   +1 more source

Paediatric Acute Generalised and Localised Exanthematous Pustulosis: A Systematic Review

JEADV Clinical Practice, Volume 5, Issue 2, Page 678-681, June 2026.
Miranda K. Branyiczky, Megan Lowe, Eric McMullen, Shireen Dumont, Narachai Julanon, Vincent Piguet, Cathryn Sibbald   +6 more
wiley   +1 more source

COVID-19 vaccine-induced acute generalized exanthematous pustulosis [PDF]

The Korean Journal of Internal Medicine, 2021
Sung-Yoon Kang, So-Young Park, Jung-Hyun Kim, Sang Min Lee, Sang Pyo Lee   +4 more
doaj   +1 more source

Sorafenib-Induced Acute Generalized Exanthematous Pustulosis

Dermatology Practical & Conceptual, 2023
Andrea Cortese, Saverio Pancetti, Tiziana Pressiani, Francesco Toso, Giovanni Fiorillo, Costanzo Antonio, Riccardo G. Borroni   +6 more
doaj   +1 more source

Naltrexone-induced acute generalized exanthematous pustulosis

JAAD Case Reports, 2023
Jason Eakes, BS, Sarah Moore, MD, Kerry Hennessy, MD, Ann Lin, DO   +3 more
doaj   +1 more source